N/A N=59 The Breast Cancer Online Rehabilitation Program
Breast Cancer
Primary: Recruitment Rate — 35; 24 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=750 eHealth Partnered Evaluation Initiative - Evaluation of the Initial Deployment of VA's Annie Texting System
Hepatitis C
Primary: Perception of HCV Treatment Success — 8; 13 Participants
Phase 3 N=467 A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
Actinic Keratosis
Primary: Complete Clearance Rate - Percentage of Participants With Treatment Success: Per-Protocol (PP) Population — 12.4; 13.6; 4.8 percentage of participants — p=0.0702
N/A N=100 Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
HIV (Human Immunodeficiency Virus) · AIDS (Acquired Immunodeficiency Syndrome)
Primary: Symptom Burden Score — 1.08; 1.06; 0.83; 0.71 score on a scale — p=0.02
Phase 2 N=20 Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Graft Versus Host Disease · Leukemia · Lymphoma
Primary: Overall Response Rate — 12; 1; 7 Participants
Phase 2 N=103 Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
Colorectal Cancer
Primary: Progression Free Survival — 7.33; 9.13 Months — p=0.046
N/A N=45 Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
Nail Growth Cessation · Intraocular Pressure
Primary: Change From Baseline in Nail Length of Hands — 13.49; 15.10; 1.34; 1.51 mm — p=0.532
Phase 3 N=164 Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
Chronic Idiopathic Constipation
Primary: Number of Spontaneous Bowel Movements (SBMs) Within 1 Week — 4.6; 4.0 number of SBMs — p=0.1290
N/A N=10 Oatmeal Effect on N-acyl-phosphatidylethanolamines
Obesity · Cardiovascular Diseases
Primary: Change in Serum N-acyl-phosphatidylethanolamine (NAPE) — -4.02 nmol/L
N/A N=241 Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers
Chronic Kidney Disease
Primary: Slope of Change in Kidney Disease Quality of Life-36 Score — 2.21; 4.13; -0.50; 3.00 Scores on a scale / Months — p=<0.05
Phase 1 N=10 Oral AGY for Celiac Disease
Celiac Disease
Primary: Number of Participants for Which Treatment Was Concluded to be Safe — 6; 18; 4; 5 participants
N/A N=3 Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye
Dry Eye Syndrome
Primary: Change From Baseline OSDI — -24.64; -26.53 units on a scale — p=0.662
N/A N=40 Biomarkers of Orthodontic Tooth Movement With Fixed Appliances and Vibration Appliance Therapy
Tooth Movement
Primary: Changes in the Expression of Salivary Biomarkers of Bone Remodeling — -1.62; 0.5; -1.95; 0.47 pg/mL
N/A N=679 AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment
Rheumatoid Arthritis
Primary: Change in Total Sharp Score (TSS) From Baseline to Month 12 Following Subcutaneous Administration of Denosumab or Placebo — 0.99; 0.72; 1.49 score on a scale — p=0.0235
N/A N=262 Right Colon Polyp Miss Rates of Water Exchange and Carbon Dioxide Insufflation Colonoscopy
Right Colon Adenoma Miss Rate · Right Colon Hyperplastic Polyp Miss Rate
Primary: Percentage of Adenomas and Hyperplastic Polyps Missed During Initial Right Colon Examination — 18.0; 36.7 percentage of all missed polyps